Des Iodo Abiraterone | CAS 1224-94-8 - Request Quote
Des Iodo Abiraterone
| SZ CAT No: | SZ-A006079 |
| CAS No | 1224-94-8 |
| Mol.F. | C19H28O |
| Mol.Wt. | 272.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
CHNS Ratio (%) :
Usage Note:
Des Iodo Abiraterone is chemically (3b)-Androsta-5,16-dien-3-ol . Des Iodo Abiraterone is supplied with detailed characterization data compliant with regulatory guideline. Des Iodo Abiraterone can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Abiraterone Acetate.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1224-94-8
Purchase 1224-94-8
Order 1224-94-8
Enquire 1224-94-8
price of 1224-94-8
1224-94-8 Supplier
1224-94-8 Manufacturer
1224-94-8 Exporter
buy high quality Des Iodo Abiraterone
Purchase Des Iodo Abiraterone
Des Iodo Abiraterone suppliers
Des Iodo Abiraterone manufacturers
Des Iodo Abiraterone price
Order Des Iodo Abiraterone
Enquire Des Iodo Abiraterone
Des Iodo Abiraterone cost
Des Iodo Abiraterone Supplier
Des Iodo Abiraterone Distributor
Des Iodo Abiraterone for Method Validation
Abiraterone Acetate Reference Standard
Des Iodo Abiraterone for ANDA Filing
Des Iodo Abiraterone for Forced Degradation Studies
Des Iodo Abiraterone Identification Standards
Des Iodo Abiraterone for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.